Prostatic adenoma--prostatic carcinoma. Questions from general practice. II. Therapy
Strohmenger, P.
Zfa. Zeitschrift für Allgemeinmedizin 56(28): 1793-1797
1980
ISSN/ISBN: 1433-6251 PMID: 6162291 Document Number: 161874
Document emailed within 1 workday
Related Documents
Kumamoto, Y.; Tsukamoto, T.; Umehara, T.; Harada, M.; Shimazaki, J.; Fuse, H.; Oshima, H.; Takeuchi, H.; Yoshida, O.; Okada, K. 1990: Clinical studies on endocrine therapy of prostatic carcinoma (3): Histopathological features of prostatic carcinoma and its prognosis Hinyokika Kiyo. Acta Urologica Japonica 36(3): 295-305Frick, J. 1971: Aspects of prostatic carcinoma for the general practice Zeitschrift für Allgemeinmedizin 47(7): 334-336
Bogdanowicz, J.F.; Bentvelsen, F.M.; Oosterom, R.; Schroeder, F.H. 1991: Evaluation of prostate-specific antigen and prostatic acid phosphatase in untreated prostatic carcinoma and benign prostatic hyperplasia Scandinavian Journal of Urology and Nephrology. Supplementum 138: 97-103
Lukacs, B.; Grange, J.C.; Comet, D.; Mc Carthy, C. 1999: Prospective follow-up of 3,228 patients suffering from clinical benign prostatic hyperplasia (BPH) treated for 3 years wi alfuzosin in general practice. BPH Group in General Practice Progres en Urologie: Journal de l'Association Francaise d'Urologie et de la Societe Francaise d'Urologie 9(2): 271-280
Schröder, F.H.; Jellinghaus, W. 1976: Prostatic adenoma and carcinoma in cell culture and heterotransplantation Progress in Clinical and Biological Research 6: 301-312
Korth, K.; Wetterauer, W.; Wetterauer, U.; Heite, H.J. 1978: Citrate and acid phosphatase in the ejaculate in prostatic carcinoma and adenoma Der Hautarzt; Zeitschrift für Dermatologie Venerologie und verwandte Gebiete 29(9): 487-489
Weinberg, D.S.; Weidner, N. 1993: Concordance of DNA content between prostatic intraepithelial neoplasia and concomitant invasive carcinoma. Evidence that prostatic intraepithelial neoplasia is a precursor of invasive prostatic carcinoma Archives of Pathology and Laboratory Medicine 117(11): 1132-1137
Sáenz de Chirife, A.M.; Bassi, A.M.; Celeste, F.; Bergdolt, D. 1991: Specific prostatic antigen in prostatic carcinoma: its relationship with tumor differentiation and clinical course Archivos Espanoles de Urologia 44(4): 405-409
Pretlow, T.G.; Whitehurst, G.B.; Pretlow, T.P.; Hunt, R.S.; Jacobs, J.M.; McKenzie, D.R.; McDaniel, H.G.; Hall, L.M.; Bradley, E.L. 1982: Decrease in creatine kinase in human prostatic carcinoma compared to benign prostatic hyperplasia Cancer Research 42(11): 4842-4848
Vozianov, A.F.; Mal'tsev, E.V.; Vodianik, N.V. 1995: The treatment of prostatic adenoma by transurethral microwave therapy Likars'ka Sprava 1995(1-2): 142-146
Shaplygin, L.V.; Sivakov, A.A. 2007: Use of cernilton in the therapy of prostatic adenoma and chronic prostatitis Urologiia 3: 35-37; 39
Bologna, M.; Festuccia, C.; Vicentini, C.; Muzi, P.; Biordi, L.; De Nicola, G.; Ventura, T. 1991: Establishment and characterization of a human prostatic carcinoma cell strain obtained from exfoliated tumor cells after prostatic massage Tumori 77(1): 70-75
Abdalla, A.M.; Oliver, J.A. 1971: SV40 virus transformed prostatic carcinoma in the hamster. I. Comparisons of lactate dehydrogenase isoenzymes with human prostatic cancer Investigative Urology 8(4): 442-447
Dormia, E.; Minervini, M.S.; Malagola, G.; Castellani, R.; Dormia, G.; Bertana, F.; Gonnella, G.; Luongo, P.; Mazza, L.; Longo, G. 1995: Radical versus conservative therapy in prostatic adenoma. Open adenomectomy Archivio Italiano di Urologia Andrologia: Organo Ufficiale di Societa Italiana di Ecografia Urologica e Nefrologica 67(1): 47-51
Maygarden, S.J.; Strom, S.; Ware, J.L. 1992: Localization of epidermal growth factor receptor by immunohistochemical methods in human prostatic carcinoma, prostatic intraepithelial neoplasia, and benign hyperplasia Archives of Pathology and Laboratory Medicine 116(3): 269-273
Shiran, M.S.; Tan, G.C.; Sabariah, A.R.; Rampal, L.; Phang, K.S. 2007: P63 as a complimentary basal cell specific marker to high molecular weight-cytokeratin in distinguishing prostatic carcinoma from benign prostatic lesions Medical Journal of Malaysia 62(1): 36-39
Kazama, T.; Mizuno, I.; Takamine, T.; Umeda, K.; Terada, T.; Ishikawa, S.; Fuse, H.; Katayama, T. 1990: Evaluation of anti-androgen therapy for benign prostatic hypertrophy by using transrectal prostatic ultrasonography Hinyokika Kiyo. Acta Urologica Japonica 36(12): 1423-1427
Schnur, S.; Keuler, F.U. 1996: Benign prostatic hyperplasia: diagnosis in general practice Fortschritte der Medizin 114(31): 412-415
Mustafaev, E.M.; Martov, A.G.; Naumov, A.G.; Siniukhin, V.N.; Shakir, F.; Merinov, D.S.; Amelin, A.V.; Al'bitskaia, A.Iu. 2007: The role of ozone therapy in prevention of pyoinflammatory complications after transurethral resection of prostatic adenoma Urologiia 2007(1): 18-23 27
Shimazaki, J.; Fuse, H.; Akimoto, S.; Sumiya, H.; Akakura, K.; Ichikawa, T. 1988: Prostatic carcinoma. I: Androgen dependency of prostatic carcinoma Gan to Kagaku Ryoho. Cancer and ChemoTherapy 15(4 Pt: 2-1): 909-916